Article
Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study.
BMC infectious diseases - 22 Sept 2017
Masenga Sepiso K, Mubila Harrison, Hamooya Benson M
Abstract excerpt
BACKGROUND: Since the recent introduction of GeneXepert for the detection of Tuberculosis (TB) drug resistance mutations in both primary resistance and acquired resistance in Zambia, little has been documented in literature on the issue of rifampicin resistance especially in the face of a high National TB burden. The study aimed to determine the prevalence of rifampicin resistance in tuberculosis patients at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
